These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32591089)

  • 1. Should we accept a higher risk of type I errors in some trials?
    Laigaard J
    Br J Anaesth; 2020 Aug; 125(2):e226-e227. PubMed ID: 32591089
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of a misspecification of response rates on type I and type II errors, in a phase II Simon design.
    Baey C; Le Deley MC
    Eur J Cancer; 2011 Jul; 47(11):1647-52. PubMed ID: 21493059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why "underpowered" trials are not necessarily unethical.
    Edwards SJ; Lilford RJ; Braunholtz D; Jackson J
    Lancet; 1997 Sep; 350(9080):804-7. PubMed ID: 9298015
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of error rates in single-arm versus randomized phase II cancer clinical trials.
    Tang H; Foster NR; Grothey A; Ansell SM; Goldberg RM; Sargent DJ
    J Clin Oncol; 2010 Apr; 28(11):1936-41. PubMed ID: 20212253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A statistics primer. Hypothesis testing.
    Kuhn JE; Greenfield ML; Wojtys EM
    Am J Sports Med; 1996; 24(5):702-3. PubMed ID: 8883697
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the statistical power for multiple tests: a case study.
    Yeo A; Qu Y
    Pharm Stat; 2009; 8(1):5-11. PubMed ID: 18381588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping boundaries adjusted for sample size reestimation and negative stop.
    Shun Z
    J Biopharm Stat; 2002 Nov; 12(4):485-502. PubMed ID: 12477071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis and importance of statistical power and sample size in empirical scientific research].
    Klimek KM
    Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How often should we expect to be wrong? Statistical power, P values, and the expected prevalence of false discoveries.
    Marino MJ
    Biochem Pharmacol; 2018 May; 151():226-233. PubMed ID: 29248599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplicity adjustment big and small in clinical studies.
    Hsu JC
    Clin Pharmacol Ther; 2010 Aug; 88(2):251-4. PubMed ID: 20592727
    [No Abstract]   [Full Text] [Related]  

  • 13. Planning and revising the sample size for a trial.
    Gould AL
    Stat Med; 1995 May 15-30; 14(9-10):1039-51; discussion 1053-5. PubMed ID: 7569499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal type I and type II error pairs when the available sample size is fixed.
    Ioannidis JP; Hozo I; Djulbegovic B
    J Clin Epidemiol; 2013 Aug; 66(8):903-910.e2. PubMed ID: 23664493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II error in the spine surgical literature.
    Bailey CS; Fisher CG; Dvorak MF
    Spine (Phila Pa 1976); 2004 May; 29(10):1146-9. PubMed ID: 15131445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Publication bias in the anesthesiology literature.
    De Oliveira GS; Chang R; Kendall MC; Fitzgerald PC; McCarthy RJ
    Anesth Analg; 2012 May; 114(5):1042-8. PubMed ID: 22344237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I and Type II error concerns in fMRI research: re-balancing the scale.
    Lieberman MD; Cunningham WA
    Soc Cogn Affect Neurosci; 2009 Dec; 4(4):423-8. PubMed ID: 20035017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and specificity of clinical trials. Randomized v historical controls.
    Sacks HS; Chalmers TC; Smith H
    Arch Intern Med; 1983 Apr; 143(4):753-5. PubMed ID: 6838297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial design in oncology: statistical power.
    Gallo C; Perrone F
    Lancet Oncol; 2004 Dec; 5(12):760-1. PubMed ID: 15600004
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical guide to sample size calculations: an introduction.
    Flight L; Julious SA
    Pharm Stat; 2016; 15(1):68-74. PubMed ID: 26585441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.